G. Ian Gallicano

2.9k citations
57 papers · 2.3k indexed · h-index 28

G. Ian Gallicano

56 papers receiving 2.2k citations

Peers

G. Ian Gallicano
Comparison fields: 5 of 115
  • Reproductive Medicine 368
  • Cancer Research 388
  • Cell Biology 403
  • Molecular Biology 1.4k
  • Public Health, Environmental and Occupational Health 505
Replace Kallayanee Chawengsaksophak with:
Kallayanee Chawengsaksophak Australia
Subhash C. Juneja United States
J Huarte Switzerland
Kenta Yashiro Japan
Naoko Irie United Kingdom
Nady Golestaneh United States
А. Н. Томилин Russia
Tetsuo Kunieda Japan
Steve Bilodeau Canada
Zhengjian Yan China
G. Ian Gallicano relative to Kallayanee Chawengsaksophak Australia Kallayanee Chawengsaksophak's profile →
Citations per field
00.5×1.5×
Kallayanee Chawengsaksophak · 1×
Citations per year

Countries citing papers authored by G. Ian Gallicano

Since Specialization
Citations

This map shows the geographic impact of G. Ian Gallicano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Ian Gallicano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Ian Gallicano more than expected).

Fields of papers citing papers by G. Ian Gallicano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Ian Gallicano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Ian Gallicano. The network helps show where G. Ian Gallicano may publish in the future.

Co-authorship network

The 25 scholars most cited alongside G. Ian Gallicano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with G. Ian Gallicano Line = papers co-authored together G. Ian Gallicano links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 202016
3 20187
4 201816
5 201427
6 20130
7 20122
8 201222
9 20117
10 201025
11 2009151
12 200892
13 2008188
14 200763
15 20064
16 200337
17 2001148
18 199859
19 199617
20 199546

About G. Ian Gallicano

G. Ian Gallicano is a scholar working on Reproductive Medicine, Cell Biology and Cancer Research, having authored 57 papers that have together received 2.3k indexed citations. Recurring topics across this work include Pluripotent Stem Cells Research (17 papers), Reproductive Biology and Fertility (13 papers), CRISPR and Genetic Engineering (9 papers), MicroRNA in disease regulation (8 papers), Skin and Cellular Biology Research (6 papers), Sperm and Testicular Function (5 papers), Microtubule and mitosis dynamics (4 papers) and Renal and related cancers (4 papers). The work is most often cited by research in Reproductive Medicine (368 citations), Cancer Research (388 citations) and Cell Biology (403 citations). G. Ian Gallicano has collaborated with scholars based in United States, South Korea and Saudi Arabia. Frequent co-authors include Kara M. Foshay, David G. Capco, Elaine Fuchs, Robert W. McGaughey, Christoph Bauer, Maria Kokkinaki, Disha Pant, Martin Dym, Valeri Vasioukhin and Linda Degenstein. Their work appears in journals such as The Journal of Cell Biology, PLoS ONE and Development.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026